Related Experiment Video
Updated: Jul 15, 2026

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
Hospital volume and late survival after cancer surgery
John D Birkmeyer1, Yating Sun, Sandra L Wong
1Michigan Surgical Collaborative for Outcomes Research and Evaluation, Department of Surgery, University of Michigan, 1500 East Medical Center Drive, Ann Arbor, MI, USA. jbirkmey@umich.edu
Context:
Although hospital procedure volume is clearly related to operative mortality with many cancer procedures, its effect on late survival is not well characterized.
Objective:
To examine relationships between hospital volume and late survival after different types of cancer resections.
Design:
Using the national Surveillance Epidemiology and End Results (SEER)-Medicare linked database (1992-2002), we identified all patients undergoing major resections for lung, esophageal, gastric, pancreatic, colon, and bladder cancer (n = 64,047). Relationships between hospital volume and survival were assessed using Cox proportional hazards models, adjusting for patient characteristics and use of adjuvant radiation and chemotherapy.
Study Participants:
U.S. Medicare patients residing in SEER regions.
Main Outcome Measures:
5-year survival.
Results:
Although there were statistically significant relationships between hospital volume and 5-year survival with all 6 cancer types, the relative importance of volume varied markedly. Absolute differences in 5-year survival probabilities rates between low-volume hospitals (LVHs) and high-volume hospitals (HVHs) ranged from 17% for esophageal cancer resection (17% vs. 34%, respectively) to only 3% for colon cancer resection (45% vs. 48%). Absolute differences in 5-year survival between LVHs and HVHs fell between these ranges for lung (6%), gastric (6%), pancreatic (5%), and bladder cancer (4%). Volume-related differences in late survival could not be attributed to differences in rates of adjuvant therapy.
Conclusions:
Along with lower operative mortality, HVHs have better late survival rates with selected cancer resections than their lower-volume counterparts. Mechanisms underlying their better outcomes and thus opportunities for improvement remain to be identified.
Related Concept Videos
Cancer Survival Analysis
Cardiomyopathy VII: Pre and Post Operative Nursing Management